다한증 치료 시장 : 시장 규모, 점유율, 성장 분석, 유형별, 치료법별, 연령별, 최종 사용자별, 지역별 - 산업 예측(2025-2032년)
Hyperhidrosis Treatment Market Size, Share, Growth Analysis, By Type (Axillary hyperhidrosis, Palmar hyperhidrosis), By Treatment (Topical treatment, Oral medication), By Age, By End-user, By Region - Industry Forecast 2025-2032
상품코드:1624009
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 다한증 치료 시장 규모는 2023년 6억 7,120만 달러로 평가되었고, 예측기간 2025년부터 2032년까지의 CAGR은 5.4%로 성장할 전망이며, 2024년 7억 744만 달러에서 2032년 10억 7,750만 달러로 확대될 전망입니다.
다한증 치료 시장은 연구개발 투자의 활성화와 2차성 다한증 질환의 유병률 상승으로 큰 성장을 이루고 있습니다. 영구적인 치료법이 존재하지 않기 때문에 제한제와 외용액이 여전히 첫 번째 치료법입니다. 혁신적인 치료 옵션에 대한 환자의 선호도 증가는 각 기업의 제품 강화에 박차를 가하고 있습니다. 2021년 10월에 Jared Brackenrich에 의해 발표된 연구에 따르면 현재 다한증은 미국 인구의 약 3%를 앓고 있으며, 이 증상이 사회적, 심리적, 직업적 기능에 영향을 미치는 것으로 강조됩니다. 또한, 개발 중인 유망한 치료법, 유리한 상환 정책, 사회적 인지도의 향상이 수요를 촉진할 가능성이 높습니다. 특히 Brickell Biotech 사의 브롬화 소프피로늄 겔의 3상 임상시험은 첨단 다한증 치료의 강한 미래를 보여줍니다.
목차
서문
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터 및 1차 데이터의 방법
시장 규모 예측
시장의 전제조건 및 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학 및 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인 및 기회
성장 억제요인 및 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
기술 분석
규제 분석
특허 분석
사례 연구
다한증 치료 시장 규모 : 유형별 및 CAGR(2025-2032년)
시장 개요
겨드랑이 다한증
수장 다한증
발바닥 다한증
기타 유형
다한증 치료 시장 규모 : 치료법별 및 CAGR(2025-2032년)
시장 개요
국소 치료
경구약
항콜린제
기타 경구약
보툴리눔툭신(보톡스) 주사
이온 도입
외과적 치료
다한증 치료 시장 규모 : 연령별 및 CAGR(2025-2032년)
시장 개요
50세까지
50세 이상
다한증 치료 시장 규모 : 최종 사용자별 및 CAGR(2025-2032년)
시장 개요
병원
외래수술센터(ASC)
피부과 클리닉
기타 최종 사용자
다한증 치료 시장 규모 : 지역별 및 CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년 대비 비교(2022-2024년)
주요 기업 프로파일
AbbVie Inc.(US)
Avanor Healthcare Ltd.(UK)
Brickell Biotech Inc.(US)
Dermadry Laboratories Inc.(Canada)
Dermavant Sciences Inc.(US)
Hugel, Inc.(South Korea)
Eirion Therapeutics, Inc.(US)
Eli Lilly and Company(US)
Intas Pharmaceuticals Ltd.(India)
Kaken Pharmaceutical Co., Ltd.(Japan)
Maruho Co., Ltd.(Japan)
miraDry, Inc.(US)
SweatBlock(US)
Roivant Sciences Ltd.(Switzerland)
Theravida, Inc.(US)
Dr. August Wolff GmbH(Germany)
Dr. Reddy's Laboratories Ltd.(India)
GSK Plc(UK)
Revance(US)
NovaMedica(Russia)
결론 및 권장사항
AJY
영문 목차
영문목차
Global Hyperhidrosis Treatment Market size was valued at USD 671.2 million in 2023 and is poised to grow from USD 707.44 million in 2024 to USD 1077.5 million by 2032, growing at a CAGR of 5.4% during the forecast period (2025-2032).
The hyperhidrosis treatment market is witnessing significant growth driven by heightened R&D investment and a rising prevalence of secondary hyperhidrosis disorders. Antiperspirants and topical solutions remain the frontline therapies as no permanent cure exists. The growing patient preference for innovative treatment options has spurred companies to enhance their offerings. Currently, hyperhidrosis affects about 3% of the U.S. population, according to a study published by Jared Brackenrich in October 2021, underscoring the condition's impact on social, psychological, and vocational functioning. Additionally, promising therapies in the pipeline, favorable reimbursement policies, and increasing public awareness are likely to fuel demand. Notably, Brickell Biotech's Phase 3 trials of sofpironium bromide gel indicate a strong future potential for advanced hyperhidrosis treatments.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hyperhidrosis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Hyperhidrosis Treatment Market Segmental Analysis
Global Hyperhidrosis Treatment Market is segmented by Type, Treatment, Age, End-user and region. Based on Type, the market is segmented into Axillary hyperhidrosis, Palmar hyperhidrosis, Plantar hyperhidrosis and Other types. Based on Treatment, the market is segmented into Topical treatment, Oral medication, Botulinum toxin injections, Iontophoresis and Surgical treatment. Based on Age, the market is segmented into Up to 50 years and Above 50 years. Based on End-user, the market is segmented into Hospitals, Ambulatory surgical centers, Dermatology clinics and Other end-users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Hyperhidrosis Treatment Market
The Global Hyperhidrosis Treatment market is driven by a growing interest among healthcare providers in exploring advanced therapies such as radiofrequency microneedling for hyperhidrosis patients. Researchers are particularly focused on assessing the long-term effectiveness of fractional microneedle radiofrequency treatments for individuals with primary axillary hyperhidrosis, utilizing the hyperhidrosis disease severity scale (HDSS) to measure significant improvements post-treatment. Additionally, tap water iontophoresis is gaining traction, demonstrating notable results in clinical trials for patients suffering from plantar and palmar hyperhidrosis. Innovations in treatment options are being propelled by recent successful studies, including the positive Phase 3 results from Brickell Biotech Inc. regarding sofpironium bromide gel, highlighting the market's potential for growth and enhanced patient quality of life.
Restraints in the Global Hyperhidrosis Treatment Market
The Global Hyperhidrosis Treatment market faces notable challenges, one of which is the limited duration of effectiveness associated with Botulinum toxin injections; patients often develop a reduced response to these treatments over time. Additionally, the financial implications and emotional strain on patients pose significant obstacles, as many insurance providers do not reimburse expenses related to hyperhidrosis treatments. This lack of coverage not only adds to the economic burden for individuals seeking relief but also contributes to their psychological distress, potentially leading to decreased treatment adherence and limiting market growth opportunities in this sector.
Market Trends of the Global Hyperhidrosis Treatment Market
The Global Hyperhidrosis Treatment market is witnessing significant growth, driven by an increasing awareness of excessive sweating conditions and the effectiveness of advanced treatment options like onabotulinumtoxinA (Botox). With its clinically proven ability to reduce sweating by 82-87% and long-lasting effects that can endure up to 14 months, Botox has become a preferred treatment choice among patients. The market is further propelled by innovations in minimally invasive procedures, a growing prevalence of hyperhidrosis, and a rise in disposable income allowing for aesthetic treatments. As demand expands, the market is poised for continued advancement through research and new therapeutic options.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies
Global Hyperhidrosis Treatment Market Size by Type & CAGR (2025-2032)
Market Overview
Axillary hyperhidrosis
Palmar hyperhidrosis
Plantar hyperhidrosis
Other types
Global Hyperhidrosis Treatment Market Size by Treatment & CAGR (2025-2032)
Market Overview
Topical treatment
Oral medication
Anticholinergics
Other oral medications
Botulinum toxin injections
Iontophoresis
Surgical treatment
Global Hyperhidrosis Treatment Market Size by Age & CAGR (2025-2032)
Market Overview
Up to 50 years
Above 50 years
Global Hyperhidrosis Treatment Market Size by End-user & CAGR (2025-2032)
Market Overview
Hospitals
Ambulatory Surgical Centers
Dermatology clinics
Other end-users
Global Hyperhidrosis Treatment Market Size & CAGR (2025-2032)
North America (Type, Treatment, Age, End-user)
US
Canada
Europe (Type, Treatment, Age, End-user)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type, Treatment, Age, End-user)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type, Treatment, Age, End-user)
Brazil
Rest of Latin America
Middle East & Africa (Type, Treatment, Age, End-user)
